Am J Surg Pathol

1. RETAMERO JA, Gulturk E, Bozkurt A, Liu S, et al
   Artificial Intelligence Helps Pathologists Increase Diagnostic Accuracy and Efficiency in the Detection of Breast Cancer Lymph Node Metastases.
   Am J Surg Pathol. 2024 May 29. doi: 10.1097/PAS.0000000000002248.
   

   >> Share

   
   

   
   Ann Surg Oncol

2. SIEGEL JB, Bertolino M, Mukherjee R, Meeder K, et al
   Racial Disparities in Breast Cancer Genetic Testing May be Mitigated by Counseling.
   Ann Surg Oncol. 2024 May 29. doi: 10.1245/s10434-024-15434.
   

   >> Share

   
   
3. SIEGEL JB, Bertolino M, Mukherjee R, Meeder K, et al
   ASO Visual Abstract: Racial Disparities in Breast Cancer Genetic Testing may be Mitigated by Counseling.
   Ann Surg Oncol. 2024 May 29. doi: 10.1245/s10434-024-15536.
   

   >> Share

   
   
4. 
   The American Society of Breast Surgeons Official Proceedings, Volume XXV 2024 Annual Meeting Scientific Session Abstracts.
   Ann Surg Oncol. 2024;31.
   

   >> Share

   
   

   
   BMC Cancer

5. AZIZ MA, Chowdhury S, Jafrin S, Barek MA, et al
   Genetic association of Interleukin-17A polymorphism in Bangladeshi patients with breast and cervical cancer: a case-control study with functional analysis.
   BMC Cancer. 2024;24:660.
   

   >> Share

   
   

   
   Br J Cancer

6. NG CW, Tsang YTM, Gershenson DM, Wong KK, et al
   The prognostic value of MEK pathway-associated estrogen receptor signaling activity for female cancers.
   Br J Cancer. 2024;130:1875-1884.
   

   >> Share

   
   

   
   Breast Cancer

7. KATARIA M, Gupta N, Kumar A, Bhoriwal S, et al
   Assessing the effectiveness of high frequency repetitive transcranial magnetic stimulation for post-mastectomy pain in breast cancer patients: A randomized controlled trial.
   Breast Cancer. 2024 May 26. doi: 10.1007/s12282-024-01598.
   

   >> Share

   
   
8. OKUYAMA H, Takada F, Taira N, Nakamura S, et al
   A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy.
   Breast Cancer. 2024 May 26. doi: 10.1007/s12282-024-01592.
   

   >> Share

   
   
9. MUR-GIMENO E, Coll M, Yuguero-Ortiz A, Navarro M, et al
   Comparison of water- vs. land-based exercise for improving functional capacity and quality of life in patients living with and beyond breast cancer (the AQUA-FiT study): a randomized controlled trial.
   Breast Cancer. 2024 May 30. doi: 10.1007/s12282-024-01596.
   

   >> Share

   
   
10. TENG L, Du J, Yan S, Xu P, et al
    A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database.
    Breast Cancer. 2024 May 27. doi: 10.1007/s12282-024-01591.
    

    >> Share

    
    

    
    Breast Cancer (Dove Med Press)

11. GU Q, Zhu M, Wang Y, Gu Y, et al
    Retrospective Analysis of Pyrotinib-Based Therapy for Metastatic Breast Cancer: Promising Efficacy in Combination with Trastuzumab.
    Breast Cancer (Dove Med Press). 2024;16:253-268.
    

    >> Share

    
    

    
    Breast Cancer Res

12. GLOTZBACH A, Rohlf K, Gonscharow A, Luke S, et al
    EDI3 knockdown in ER-HER2+ breast cancer cells reduces tumor burden and improves survival in two mouse models of experimental metastasis.
    Breast Cancer Res. 2024;26:87.
    

    >> Share

    
    
13. RAGHURAM N, Temel EI, Kawamata T, Kozma KJ, et al
    Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formation.
    Breast Cancer Res. 2024;26:86.
    

    >> Share

    
    
14. JONES LI, Marshall A, Geach R, Elangovan P, et al
    Optimising the diagnostic accuracy of First post-contrAst SubtracTed breast MRI (FAST MRI) through interpretation-training: a multicentre e-learning study, mapping the learning curve of NHS Breast Screening Programme (NHSBSP) mammogram readers using a
    Breast Cancer Res. 2024;26:85.
    

    >> Share

    
    
15. KUKLINSKI D, Blum M, Subelack J, Geissler A, et al
    Breast cancer patients enrolled in the Swiss mammography screening program "donna" demonstrate prolonged survival.
    Breast Cancer Res. 2024;26:84.
    

    >> Share

    
    
16. LIU C, Sun M, Arefan D, Zuley M, et al
    Deep learning of mammogram images to reduce unnecessary breast biopsies: a preliminary study.
    Breast Cancer Res. 2024;26:82.
    

    >> Share

    
    

    
    Breast Cancer Res Treat

17. MENES TS, Zippel D, Sklair-Levy M, Friedman E, et al
    Clinical breast exam contribution to breast cancer diagnosis in BRCA mutation carriers vs. average to intermediate risk women.
    Breast Cancer Res Treat. 2024 May 26. doi: 10.1007/s10549-024-07345.
    

    >> Share

    
    
18. ISOGAI A, Nozawa K, Nakakami A, Komaki R, et al
    Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study.
    Breast Cancer Res Treat. 2024 May 26. doi: 10.1007/s10549-024-07367.
    

    >> Share

    
    
19. REWCASTLE E, Skaland I, Gudlaugsson E, Fykse SK, et al
    The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer.
    Breast Cancer Res Treat. 2024 May 26. doi: 10.1007/s10549-024-07352.
    

    >> Share

    
    
20. LUBARSKY M, Hernandez AE, Collie BL, Westrick AC, et al
    Does structural racism impact receipt of NCCN guideline-concordant breast cancer treatment?
    Breast Cancer Res Treat. 2024 May 29. doi: 10.1007/s10549-024-07245.
    

    >> Share

    
    
21. VAN DER MERWE NC, Buccimazza I, Rossouw B, Araujo M, et al
    Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients.
    Breast Cancer Res Treat. 2024 May 30. doi: 10.1007/s10549-024-07362.
    

    >> Share

    
    
22. ATRE SY, Soulos PR, Kuderer NM, Gross CP, et al
    Characterization of time toxicity in older patients with metastatic breast cancer.
    Breast Cancer Res Treat. 2024 May 31. doi: 10.1007/s10549-024-07379.
    

    >> Share

    
    

    
    Cancer Lett

23. LIN Z, Chen L, Wang Y, Zhang T, et al
    Improving Ultrasound Diagnostic Precision for Breast Cancer and Adenosis with Modality-Specific Enhancement (MSE) - Breast Net.
    Cancer Lett. 2024 May 23:216977. doi: 10.1016/j.canlet.2024.216977.
    

    >> Share

    
    
24. LV Y, Sun S, Zhang J, Wang C, et al
    Loss of RBM45 inhibits breast cancer progression by reducing the SUMOylation of IRF7 to promote IFNB1 transcription.
    Cancer Lett. 2024 May 24:216988. doi: 10.1016/j.canlet.2024.216988.
    

    >> Share

    
    

    
    Clin Breast Cancer

25. KO G, Naganathan G, Reel E, Cleland J, et al
    The Impact of COVID-19 on Breast Cancer Care: A Qualitative Analysis of Surgeons' Perspectives.
    Clin Breast Cancer. 2024 Apr 25:S1526-8209(24)00111.
    

    >> Share

    
    

    
    Clin Cancer Res

26. GOUGH SM, Flanagan JJ, Teh J, Andreoli M, et al
    Oral estrogen receptor PROTAC(R) vepdegestrant (ARV-471) is highly efficacious as monotherapy and in combination with CDK4/6 or PI3K/mTOR pathway inhibitors in preclinical ER+ breast cancer models.
    Clin Cancer Res. 2024 May 31. doi: 10.1158/1078-0432.CCR-23-3465.
    

    >> Share

    
    

    
    Eur J Cancer

27. HAN W, Zhang DD, Zhang YW, Shi LZ, et al
    Letter re: Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: A systematic review and meta-analysis.
    Eur J Cancer. 2024 May 22:114126. doi: 10.1016/j.ejca.2024.114126.
    

    >> Share

    
    

    
    Eur Radiol

28. ZUIANI C, Mansutti I, Caronia G, Linda A, et al
    Added value of the EUSOBI diffusion levels in breast MRI.
    Eur Radiol. 2024;34:3352-3363.
    

    >> Share

    
    
29. WANG L, Wang P, Shao H, Li J, et al
    Role of contrast-enhanced mammography in the preoperative detection of ductal carcinoma in situ of the breasts: a comparison with low-energy image and magnetic resonance imaging.
    Eur Radiol. 2024;34:3342-3351.
    

    >> Share

    
    

    
    J Biol Chem

30. PANDEY A, Kakani P, Shukla S
    CTCF and BORIS-mediated Autophagy regulation via Alternative splicing of BNIP3L in Breast Cancer.
    J Biol Chem. 2024 May 27:107416. doi: 10.1016/j.jbc.2024.107416.
    

    >> Share

    
    

    
    J Clin Oncol

31. SORSCHER S
    Omission of Radiotherapy for Women With Low-Risk Invasive Cancers That Have a Ductal Carcinoma In Situ Component.
    J Clin Oncol. 2024;42:1998.
    

    >> Share

    
    
32. RECHT A
    Internal Mammary Node Irradiation Debate: Case Closed? Not Yet, and Maybe Never.
    J Clin Oncol. 2024;42:1871-1874.
    

    >> Share

    
    
33. AZIM HA JR, Niman SM, Partridge AH, Demeestere I, et al
    Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy.
    J Clin Oncol. 2024 May 29:JCO2302292. doi: 10.1200/JCO.23.02292.
    

    >> Share

    
    

    
    J Surg Oncol

34. DI PACE B, Padley RH
    Enhancing treatment compliance in breast cancer patients: A multi-faceted approach.
    J Surg Oncol. 2024 May 27. doi: 10.1002/jso.27679.
    

    >> Share

    
    

    
    JAMA

35. MANSON JE, Crandall CJ, Rossouw JE, Chlebowski RT, et al
    The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
    JAMA. 2024;331:1748-1760.
    

    >> Share

    
    

    
    Mod Pathol

36. AJABNOOR R, Zhang G, Hu Y, Gao Y, et al
    Breast Cancer with HER2 IHC 2+ and Average HER2 Signals/Cell >/= 6 and HER2/CEP17 Ratio < 2: A Multi-Institutional Cohort Analysis Emphasizing Outcome and Molecular Subtype.
    Mod Pathol. 2024 May 27:100530. doi: 10.1016/j.modpat.2024.100530.
    

    >> Share

    
    
37. INGEBRIKTSEN LM, Svanoe AA, Saele AKM, Humlevik ROC, et al
    Age-related clusters and favorable immune phenotypes in breast cancer of the young.
    Mod Pathol. 2024 May 27:100529. doi: 10.1016/j.modpat.2024.100529.
    

    >> Share

    
    

    
    NPJ Breast Cancer

38. POWELL RT, Rinkenbaugh AL, Guo L, Cai S, et al
    Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer.
    NPJ Breast Cancer. 2024;10:37.
    

    >> Share

    
    
39. FU C, Duan S, Zhou X, Meng Y, et al
    Overexpression of COL11A1 confers tamoxifen resistance in breast cancer.
    NPJ Breast Cancer. 2024;10:38.
    

    >> Share

    
    

    
    PLoS Genet

40. DENNIS M, Hurley A, Bray N, Cordero C, et al
    Her2 amplification, Rel-A, and Bach1 can influence APOBEC3A expression in breast cancer cells.
    PLoS Genet. 2024;20:e1011293.
    

    >> Share

    
    

    
    PLoS One

41. FU Y, Zhou J, Li J
    Diagnostic performance of ultrasound-based artificial intelligence for predicting key molecular markers in breast cancer: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0303669.
    

    >> Share

    
    
42. ALASMARI A
    Achillea fragrantissima (Forssk.) Sch.Bip instigates the ROS/FADD/c-PARP expression that triggers apoptosis in breast cancer cell (MCF-7).
    PLoS One. 2024;19:e0304072.
    

    >> Share

    
    
43. ZHOU K, Robert M, Seegers V, Blanc-Lapierre A, et al
    Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
    PLoS One. 2024;19:e0304556.
    

    >> Share

    
    
44. PRAMANIK P, Roy A, Cuevas E, Perez-Cisneros M, et al
    DAU-Net: Dual attention-aided U-Net for segmenting tumor in breast ultrasound images.
    PLoS One. 2024;19:e0303670.
    

    >> Share

    
    
45. ELGHOROURY EA, Abdelghafar EE, Kamel S, Awadallah E, et al
    Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer.
    PLoS One. 2024;19:e0298536.
    

    >> Share

    
    

    
    Radiol Artif Intell

46. PEDEMONTE S, Tsue T, Mombourquette B, Truong Vu YN, et al
    A Semiautonomous Deep Learning System to Reduce False-Positive Findings in Screening Mammography.
    Radiol Artif Intell. 2024 Apr 10:e230033. doi: 10.1148/ryai.230033.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

47. MITTAL S, Chung M
    Assessment of AI Risk Scores on Screening Mammograms Preceding Breast Cancer Diagnosis.
    Radiol Imaging Cancer. 2024;6:e249011.
    

    >> Share

    
    

    
    Science

48. HOULAHAN KE, Khan A, Greenwald NF, Vivas CS, et al
    Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity.
    Science. 2024;384:eadh8697.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share